Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum

BACKGROUND: Long regarded as an epicenter of drug-resistant malaria, Southeast Asia continues to provide new challenges to the control of Plasmodium falciparum malaria. Recently, resistance to the artemisinin combination therapy partner drug piperaquine has been observed in multiple locations across...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Malar J
Auteurs principaux: Ansbro, Megan R., Jacob, Christopher G., Amato, Roberto, Kekre, Mihir, Amaratunga, Chanaki, Sreng, Sokunthea, Suon, Seila, Miotto, Olivo, Fairhurst, Rick M., Wellems, Thomas E., Kwiatkowski, Dominic P.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Methodology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7218657/
https://ncbi.nlm.nih.gov/pubmed/32404110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-020-03249-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires